The serologic screening for celiac disease in the general population (blood donors) and in some high-risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech republic

. 2002 ; 47 (6) : 753-8.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid12630332

The prevalence of celiac disease (CD) was determined in healthy blood donors and in high-risk groups of adults (a total of 1835 adults--randomly selected 1312 healthy blood donors, 102 patients with primary osteoporosis, 58 patients with autoimmune diseases and 365 infertile women). It was calculated on the basis of a two-step serologic screening method--in the first step IgA and IgG antigliadin antibodies (AGA) and IgA anti-gamma-glutamyltransferase ('transglutaminase') antibodies (ATG) were estimated, in the second step sera positive for IgA AGA and/or IgA ATG were examined for antiendomysial IgA (AEA) antibodies. Immunoenzymic assay (ELISA) was used for determining of AGA and ATG antibodies; immunofluorescence method, performed on human umbilical cord tissue, was used for assaying of AEA antibodies. Total serum IgA level in only IgG AGA positive subjects was measured by routine turbidimetric method. 0.45% of healthy blood donors, 0.98% of osteoporotic patients, 2.7% of patients suffering from autoimmune disease and 1.13% of women with infertility considered as immunologically mediated were found to be positive in both steps of serologic screening (AGA and/or ATG and antiendomysium positive). The presumed high prevalence of seropositivity for CD in apparently healthy Czech adult population was confirmed. In the high-risk groups, the prevalence of seropositivity for CD was approximately 2-4 times higher than in healthy blood donors. The real prevalence of CD in the tested groups, however, can be estimated after performing small intestinal biopsy in the seropositive patients.

Zobrazit více v PubMed

Gut. 1994 Jun;35(6):776-8 PubMed

Am J Gastroenterol. 2000 Mar;95(3):689-92 PubMed

Scand J Gastroenterol. 1994 May;29(5):457-61 PubMed

Diabetes Metab Res Rev. 2003 Jan-Feb;19(1):69-75 PubMed

Gastroenterology. 2001 Feb;120(3):636-51 PubMed

Gut. 1994 Sep;35(9):1215-8 PubMed

Pediatrics. 2001 Jan;107(1):42-5 PubMed

Scand J Gastroenterol. 1998 May;33(5):494-8 PubMed

Ital J Gastroenterol Hepatol. 1999 Oct;31(7):584-6 PubMed

Acta Paediatr. 2000 Dec;89(12):1426-30 PubMed

Folia Microbiol (Praha). 1998;43(5):545-50 PubMed

Nat Med. 1997 Jul;3(7):797-801 PubMed

Clin Immunol Immunopathol. 1997 Dec;85(3):289-96 PubMed

J Pediatr Gastroenterol Nutr. 2000 Nov;31(5):513-9 PubMed

Lancet. 1997 Nov 8;350(9088):1370 PubMed

Immunol Lett. 1988 Apr;17(4):335-8 PubMed

QJM. 1998 Dec;91(12):853-60 PubMed

Scand J Gastroenterol. 2000 Feb;35(2):181-3 PubMed

Lancet. 1994 Jan 22;343(8891):200-3 PubMed

Lancet. 1997 Apr 12;349(9058):1096-7 PubMed

Gut. 1989 Mar;30(3):333-8 PubMed

Acta Paediatr Suppl. 1996 May;412:29-35 PubMed

Dig Dis Sci. 1995 Sep;40(9):1902-5 PubMed

Acta Paediatr Suppl. 1996 May;412:56-7 PubMed

Scand J Gastroenterol. 2000 Apr;35(4):398-402 PubMed

BMJ. 1999 Jul 24;319(7204):236-9 PubMed

J Autoimmun. 2000 Dec;15(4):441-9 PubMed

Scand J Gastroenterol. 1996 Jan;31(1):61-7 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace